Abstracts Archive - Page 774 of 1683 - ATC Abstracts

2018 American Transplant Congress
Outcomes of Very Old Kidney Recipients of Grafts from Very Old Donors
H. Trujillo, A. García, T. Cavero, B. Redondo, C. Moliz, T. Bada, E. González, M. Praga, A. Andrés.
Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Aims: Describe the outcomes of very old kidney recipients of grafts from very old donors. Identify pretransplant clinical factors associated with graft and recipient survival.Methods:…
2018 American Transplant Congress
Outcomes and Risk Factors of Kidney Transplantation from Pediatric Donors to Adult Recipients
G. Chen, X. Liu, C. Wang, Z. Wu, C. Wang, L. Chen.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Objective To investigate the outcomes of kidney transplantation from pediatric donors to adult recipients, and explore the risk factors for DGF and graft loss after…
2018 American Transplant Congress
Outcomes of Donor and Recipient Obesity in Kidney Transplantation
J. Buggs,¹ R. Mehta,² M. Adesunkanmi,² J. Boone,² E. Rogers,³ A. Kumar,⁴ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Introduction: Obesity (BMI >30) is a world health epidemic projected to increase the incidence of diabetes, the leading cause of kidney failure. The shortage of…
2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…
2018 American Transplant Congress
Reducing Discards for Deceased Kidney Donors over Age 50 by Restricting Biopsy Criteria
C. Hostetler, J. Rogge, B. Nicely, S. Rudich.
Clinical Division, Gift of Life Michigan, Ann Arbor, MI.
The placement of kidneys from deceased organ donors of advanced age is an ongoing challenge. An Organ Procurement Organization (OPO) evaluated its discard rate for…
2018 American Transplant Congress
New Factors Predicting Delayed Graft Function: A Multi-Center Cohort Study Based on Kidney Donation after Brain Death Followed by Circulatory Death
Q. Sun,¹ H. Zhou,² M. Lin,³ X. Hua,¹ L. Hong,¹ Z. Huang,¹ N. Na,¹ R. Cai,³ G. Wang,² Q. Sun.¹
¹The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; ²The First Affiliated Hospital, Jilin University, Changchun, China; ³The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Background. Delayed graft function (DGF) is a common complication following kidney transplantation that exerts an adverse impact on graft outcomes. Donation after brain death followed…
2018 American Transplant Congress
Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation
S. Udomkarnjananun,¹ N. Townamchai,¹ K. Iampenkhae,² Y. Avihingsanon,¹ S. Eiam-Ong,¹ K. Praditpornsilpa.¹
¹Nephrology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ²Pathology, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Delayed graft function (DGF) is considered as a risk factor for long-term allograft failure and rejection episodes.There is currently no biomarker in the immediate post-kidney…
2018 American Transplant Congress
Kidney Transplantation from Uncontrolled Donation after Circulatory Death, Good Outcomes after Very Long Time
M. Molina,¹ J. Cabrera,² E. Gonzalez,¹ A. Hernandez,¹ P. Natalia,¹ A. Andres.¹
¹Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain; ²Department of Nephrology, Hospital Evangelico, Montevideo, Uruguay.
Introduction: Kidney transplantation (KT) is the best renal replacement therapy but the shortage of organ is the main limitation. Uncontrolled Donation after Circulatory Death (uDCD)…
2018 American Transplant Congress
Allogeneic Mesenchymal Stem Cells as Induction Therapy Are Safe and Feasible in Renal Allografts: Pilot Results of a Multicenter Randomized Controlled Trial
Q. Sun,¹ F. Han,¹ M. Zhao,² R. Cao,³ D. Zhao,¹ Z. Huang,¹ L. Hong,¹ Y. Peng,¹ Q. Sun.¹
¹Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; ²Zhujiang Hospital, Southern Medical University, Guangzhou, China; ³Second Affiliated Hospital, Guangzhou Traditional Chinese Medicine University, Guangzhou, China.
Background: Delayed graft function (DGF) and acute rejection lead to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair…
2018 American Transplant Congress
Ischemia-Free Liver Transplantation for Fatty Liver Grafts in Human
W. Ju, S. Huang, Z. Guo, G. Chen, X. He.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
BACKGROUND&AIMS: Fatty liver diseases have led to a continuous increase of available donor livers containing fat. Fatty liver grafts were identified as an independent risk…